Concepedia

Mark Mirochnick

MM

Statistics

Publications

46

Citations

2.4K

H-Index

24

Active since

1991

Affiliations

Boston University(Current)

University of California San Diego

Harvard University

Boston Medical Center

Johns Hopkins University

Mark Mirochnick is an author at Boston University specializing in pharmacokinetics, pharmacology, and antiretroviral therapy.

ORCID

Publications per year

1991–2024

46

Publications

46

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission

J. Brooks Jackson, Graziella Becker‐Pergola, Laura Guay et al. · AIDS · 2000 · 213 citations

, , +17

Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates

Mark Mirochnick, Terry Fenton, Paul Gagnier et al. · The Journal of Infectious Diseases · 1998 · 197 citations · Full text

, , +13

Effect of training traditional birth attendants on neonatal mortality (Lufwanyama Neonatal Survival Project): randomised controlled study

Christopher Gill, Grace Phiri-Mazala, Nicholas Guerina et al. · BMJ · 2011 · 167 citations · Full text

, , +17

Designing Drug Trials: Considerations for Pregnant Women

Jeanne S. Sheffield, David Siegel, Mark Mirochnick et al. · Clinical Infectious Diseases · 2014 · 128 citations · Full text

, , +15

Antiretroviral Concentrations in Breast‐Feeding Infants of Women in Botswana Receiving Antiretroviral Treatment

Roger Shapiro, Diane T. Holland, Edmund V. Capparelli et al. · The Journal of Infectious Diseases · 2005 · 122 citations · Full text

, , +14

1–5 of 46